Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Tessa M Schurink-van 't Klooster"'
Autor:
Tessa M. Schurink‐van ’t Klooster, Albert G. Siebers, Joske Hoes, Folkert J. vanKemenade, Johannes Berkhof, Johannes A. Bogaards, Hester E. deMelker
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11786-11794 (2023)
Abstract Background The first HPV‐vaccine eligible cohorts in the Netherlands will enter the cervical screening program in 2023. However, a substantial number of young women already have had a cervical sample taken before entry into the regular scr
Externí odkaz:
https://doaj.org/article/0493e70b23d14ab59d97e807604f0375
Autor:
Joske Hoes, Audrey J. King, Hester E. de Melker, Johannes Berkhof, Tessa M Schurink-van 't Klooster, Johannes A. Bogaards
Publikováno v:
Journal of Infectious Diseases. Oxford University Press
The Journal of infectious diseases, 226(4), 634-643. Oxford University Press
Hoes, J, King, A J, Klooster, T M S V, Berkhof, J, Bogaards, J A & de Melker, H E 2022, ' Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine : Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule ', The Journal of infectious diseases, vol. 226, no. 4, pp. 634-643 . https://doi.org/10.1093/infdis/jiab250, https://doi.org/10.1093/infdis/jiab250
The Journal of infectious diseases, 226(4), 634-643. Oxford University Press
Hoes, J, King, A J, Klooster, T M S V, Berkhof, J, Bogaards, J A & de Melker, H E 2022, ' Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine : Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule ', The Journal of infectious diseases, vol. 226, no. 4, pp. 634-643 . https://doi.org/10.1093/infdis/jiab250, https://doi.org/10.1093/infdis/jiab250
Background In the Netherlands, the bivalent human papillomavirus (HPV) vaccine has been offered to preadolescent girls via the National Immunization Program in a 2-dose schedule since 2014. The current study estimates vaccine effectiveness (VE) again
Autor:
Marianne A B van der Sande, M. Hooiveld, Tessa M Schurink van 't Klooster, Christian J. P. A. Hoebe, Birgit H B van Benthem, Petra J. Woestenberg, Johannes A. Bogaards, Alejandra E Guevara Morel
Publikováno v:
Clinical Infectious Diseases, 73(2), 291-297. Oxford University Press
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Woestenberg, P J, Guevara Morel, A E, Bogaards, J A, Hooiveld, M, Schurink-Van 't Klooster, T M, Hoebe, C J P A, Van Der Sande, M A B & Van Benthem, B H B 2021, ' Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients ', Clinical Infectious Diseases, vol. 73, no. 2, pp. 291-297 . https://doi.org/10.1093/cid/ciaa582
Clinical Infectious Diseases, 73(2), 291-297
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Woestenberg, P J, Guevara Morel, A E, Bogaards, J A, Hooiveld, M, Schurink-Van 't Klooster, T M, Hoebe, C J P A, Van Der Sande, M A B & Van Benthem, B H B 2021, ' Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients ', Clinical Infectious Diseases, vol. 73, no. 2, pp. 291-297 . https://doi.org/10.1093/cid/ciaa582
Clinical Infectious Diseases, 73(2), 291-297
Background There is ongoing debate about the possible protective effect of the bivalent human papillomavirus (2vHPV) vaccine, targeting oncogenic types HPV-16/18, against anogenital warts (AGWs), commonly attributed to HPV-6/11. We performed a retros
Autor:
Fiona R. M. van der Klis, Hester E. de Melker, Anne-Marie Buisman, Marjan J.M. Bogaard, Marij J. P. Welters, Hella Pasmans, Tessa M Schurink-van 't Klooster, Sjoerd H. van der Burg, Debbie M. van Rooijen
Publikováno v:
Vaccine, 37(49), 7280-7288
Background In view of further reduction of HPV vaccination schedules, gaining more insight into humoral and cellular immune responses after a single HPV vaccine is of great interest. Therefore, these responses were evaluated after different doses of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a849b5981faa3bf7f720f237a3a16035
http://hdl.handle.net/1887/121187
http://hdl.handle.net/1887/121187
Autor:
Rutger M. Schepp, Tessa M Schurink-van 't Klooster, Robine Donken, Fiona R. M. van der Klis, Hester E. de Melker
Publikováno v:
Schurink-van 't Klooster, T M, Donken, R, Schepp, R M, van der Klis, F R M & de Melker, H E 2018, ' Persistence of immune response following bivalent HPV vaccination : A follow-up study among girls routinely vaccinated with a two-dose schedule ', Vaccine, vol. 36, no. 49, pp. 7580-7587 . https://doi.org/10.1016/j.vaccine.2018.10.018
Vaccine, 36(49), 7580-7587. Elsevier BV
Vaccine, 36(49), 7580-7587. Elsevier BV
Background: In this cohort study, we examined antibody levels and avidity after a two-dose schedule (0, 6 months) of the bivalent HPV-vaccine in girls routinely vaccinated in the Dutch HPV-vaccination program, up to 2 years following vaccination. Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63e1cf0f699de38e433237be4b96db4a
https://research.vumc.nl/en/publications/bfd12f13-5a25-41c9-8e01-fcfcec3913b7
https://research.vumc.nl/en/publications/bfd12f13-5a25-41c9-8e01-fcfcec3913b7
Autor:
G. J. Boland, Hester E. de Melker, Rob van Binnendijk, Cécile A. C. M. van Els, Sigrid Gouma, Tessa M Schurink-van 't Klooster, Patricia Kaaijk, Hinke I. ten Hulscher, Marion Koopmans
Publikováno v:
Vaccine, 34(35), 4166-4171. Elsevier
Background Similar to other recent mumps genotype G outbreaks worldwide, most mumps patients during the recent mumps genotype G outbreaks in the Netherlands had received 2 doses of measles, mumps and rubella (MMR) vaccine during childhood. Here, we i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fae45e923291345b0db43451ea5f2879
https://pure.eur.nl/en/publications/3dc7e4f1-1c51-4a84-8a6e-de3d8691eb24
https://pure.eur.nl/en/publications/3dc7e4f1-1c51-4a84-8a6e-de3d8691eb24
Autor:
Hester E. de Melker, Mirjam J. Knol, Marianne A B van der Sande, Tessa M Schurink-van 't Klooster
Publikováno v:
BMC Infectious Diseases [E], 15(148). BioMed Central
BMC Infectious Diseases
BMC Infectious Diseases
Background Several studies suggested that vaccines could have non-specific effects on mortality depending on the type of vaccine. Non-specific effects seem to be different in boys and girls. In this study we want to investigate whether there are diff
Autor:
G. J. Boland, Sigrid Gouma, Hester E. de Melker, Tessa M Schurink-van 't Klooster, Pulak R. Goswami, Jeroen Kerkhof, Gaby Smits, Marion Koopmans, Cécile A. C. M. van Els, Rob van Binnendijk, Susan Hahné, Ann C. T. M. Vossen
Publikováno v:
Open Forum Infectious Diseases
Open Forum Infectious Diseases, 1(3). Oxford University Press
Open Forum Infectious Diseases, 1(3). Oxford University Press
Since the end of 2009, various mumps outbreaks have occurred in the Netherlands. The outbreaks affected mostly young adults, who had been twice vaccinated with the measles, mumps, and rubella (MMR) vaccine in childhood [1]. This phenomenon could be d
Autor:
M.J. Knol, Rutger M. Schepp, Chris J.L.M. Meijer, Tessa M Schurink-van 't Klooster, Hester E. de Melker, Fiona R. M. van der Klis, Robine Donken
Publikováno v:
Journal of Infectious Diseases. Oxford University Press
Donken, R, Schurink-van 't Klooster, T M, Schepp, R M, van der Klis, F R M, Knol, M J, Meijer, C J L M & de Melker, H E 2016, ' Immune responses after two-versus three-doses of HPV vaccination up to 4½ years post vaccination : an observational study among Dutch routinely vaccinated girls (HPV2D) ', Journal of Infectious Diseases . https://doi.org/10.1093/infdis/jiw588
Donken, R, Schurink-van 't Klooster, T M, Schepp, R M, van der Klis, F R M, Knol, M J, Meijer, C J L M & de Melker, H E 2016, ' Immune responses after two-versus three-doses of HPV vaccination up to 4½ years post vaccination : an observational study among Dutch routinely vaccinated girls (HPV2D) ', Journal of Infectious Diseases . https://doi.org/10.1093/infdis/jiw588
BACKGROUND: In 2014 the Netherlands switched from three- to two-doses for routine vaccination with the prophylactic bivalent human papillomavirus (HPV)-vaccine. This study explored whether antibody responses are non-inferior after two- compared to th